Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse events.
about
Sustained-release steroids for the treatment of diabetic macular edema.Systematic Evaluation of Corticosteroid Use in Obese and Non-obese Individuals: A Multi-cohort Study.Long-term side effects of glucocorticoids.Diabetology and oncology meet in a network model: union is strength.Long-term glucocorticoid concentrations as a risk factor for childhood obesity and adverse body-fat distribution.Rituximab in children with steroid-dependent nephrotic syndrome: experience of a tertiary center and review of the literature.New Synthetic Methods for Phosphate Labeling.Nuclear Receptor Function through Genomics: Lessons from the Glucocorticoid Receptor.BclI Glucocorticoid Receptor Polymorphism in Relation to Arterial Stiffening and Cardiac Structure and Function: The Hoorn and CODAM Studies.Efficacy and Safety of Vedolizumab in Ulcerative Colitis and Crohn's Disease Patients Stratified by Age.Magnetic Nanoparticle Mediated Steroid Delivery Mitigates Cisplatin Induced Hearing Loss.Longitudinal study of short-term corticosteroid use by working-age adults with diabetes mellitus: Risks and mitigating factors.Differing trends in the incidence of vascular comorbidity in MS and the general population.Stress and Obesity: Are There More Susceptible Individuals?Obesity and cortisol: New perspectives on an old theme.Temozolomide Plus Bevacizumab in Elderly Patients with Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial (ATAG).
P2860
Q38591296-D76DFAC2-727A-4809-819B-93C8FE643517Q38616876-B5BCE94D-8074-4CB1-845A-5C1D79525C1DQ38703908-0FD88F4D-B74F-4D8C-8A56-2E0F5DBAA3FFQ38728033-677FA001-13B8-4F2E-BF30-9B85CBD642F3Q38848981-4A17D23C-7B3A-448B-8E75-2812C88EEEA9Q38895019-1879F6FD-2201-431C-B456-371C1E053460Q39263805-5F0E73C2-4B63-46A8-9F07-70E6E682E5FBQ39299559-3080461C-1366-4E1C-964F-35CD5E5F41E8Q40376882-EDFBD52B-BDFA-4359-A9E7-BD53B3E8C7EEQ40378196-3363E3C9-4BCA-40BB-A0CF-7177B3A653F3Q41683993-80C24E13-FFE7-4C87-BA8C-1BDD69198774Q47691007-928AA657-5EE4-4235-83D9-AA28D7FA841BQ49301696-69A508C5-34E4-4B11-A223-D7C40B6564BBQ52319427-B0878FA6-B571-470D-8E7B-AEB1B637AF0DQ53484842-6A5B9D70-28B1-4B2B-BDBC-0FD7E2DA2E1DQ55029808-E7428C67-57A1-4661-9B79-7BBF2A96EB84
P2860
Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse events.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Systemic glucocorticoid therap ...... cardiovascular adverse events.
@en
type
label
Systemic glucocorticoid therap ...... cardiovascular adverse events.
@en
prefLabel
Systemic glucocorticoid therap ...... cardiovascular adverse events.
@en
P2860
P1433
P1476
Systemic glucocorticoid therap ...... cardiovascular adverse events
@en
P2093
Laurence Fardet
P2860
P2888
P304
P356
10.1007/S40265-014-0282-9
P50
P577
2014-10-01T00:00:00Z
P6179
1009748751